• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA and Allergan co-hosted the Webinar: Application of RWD and Fast-track Approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone

NMPA and Allergan co-hosted the Webinar: Application of RWD and Fast-track Approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone

Real-world data Application in China
Friday, 05 June 2020 / Published in Medical Device

NMPA and Allergan co-hosted the Webinar: Application of RWD and Fast-track Approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone

On 13.05.2020, various departments of the NMPA hosted a webinar with a representative from Allergan, the US global pharmaceutical company that was recently acquired by AbbVie Inc, another US company. Allergan’s glaucoma drainage tube was approved by the NMPA on 26.03.2020 to become the first imported medical device utilizing real-world data to register in China.

The webinar topic was real world data research and how to use real world data in registration applications.

The authorities and persons involved were: Mrs. Xuan HE (China Pharmaceutical News), Mrs. Hong LU (reviewer from CMDE), Mrs. Ning ZHU (Vice Director of Hainan MPA), Prof. Xin SUN (Director of The Chinese Cochrane Center), Mr. Lipeng WAN (RA Director, Allergan Shanghai), and Mr. Jun XU (China Health Media Group).

Apart from sharing their views on the application and transformation of real-world data in China, some clarifications were provided about the latest definitions of real-world data, real-world study/research, and real-world evidence applicable in China:

RWD (Real-world data) refers to the data derived from health care settings and sources other than traditional clinical trials to reflect the patients’ health status and the delivery of health care.

RWS/RWR (Real-world study/research) refers to the study and research of RWD on scientific topics and the comprehensive use of medical methods from epidemiology, biostatistics, evidence-based medicine, etc.

RWE (Real-world evidence) refers to the clinical evidence regarding the usage and potential risks / benefits of a medical product derived from the analysis of RWD.

During the registration process of Allergan’s glaucoma drainage tube, the NMPA also utilized the real-world data collected in Hainan’s Boao Lecheng International Medical Tourism Pilot Zone to evaluate ethnic diversity among patients.

Mr. Wan of Allergan Shanghai was asked about his registration experience using real-world data but declined to provide any details about the registration, other than that communication is important and their team is hardworking.

We have separately reported about the sharp increase in products applying to enter the Hainan Pilot Zone.

By Jacky Li. Contact Cisema to learn more.

Tagged under: Hainan Boao Lecheng International Medical Tourism Pilot Zone, Real-world data, Real-world evidence, Real-world research, Real-world study, RWD, RWE, RWR, RWS

What you can read next

Sampling Inspection
NMPA Initiates Working Plan for Medical Device Sampling Inspection
China medical device registration review requirements
China medical device registration review requirements updates in September 2022 by NMPA
China Regulatory Round-up for Medical Devices in March 2021

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.